AwardedSpainGoodsFramework agreement€2,517,317
Adjudicación del Contrato Basado del Acuerdo Marco del Suministro del Medicamento TOCILIZUMAB del Consorci Sanitari Integral
- Published
- Published 1 June 2026
Overview
The Consorci Sanitari Integral has awarded a contract for the supply of the medicine Tocilizumab under a framework agreement, with an estimated value of 2,517,317 EUR. The contract was awarded on 29 May 2026 to Celltrion Farmaceutica España SL and Fresenius Kabi España, S.A.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €2,517,317
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 1 June 2026
Various medicinal products
Award outcome
- Award date
- 29 May 2026
- Contract period
- 29 May 2026 → 24 May 2027
- Celltrion Farmaceutica España SL
- FRESENIUS KABI ESPAÑA, S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
1 June 2026
Contracting authority
Consorci Sanitari Integral
Procuring entityL’Hospitalet de Llobregat, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.